Hypnotic and Sleep Quality–Enhancing Properties of kavain (cas 1635-33-2) in Sleep-Disturbed Rats

Add time:07/26/2019    Source:sciencedirect.com

The present study was performed to investigate the effects of kavain (cas 1635-33-2) on the sleep-wake cycle in comparison with that of rilmazafone and diphenhydramine using sleep-disturbed rats. Electrodes for the electroencephalogram (EEG) and electromyogram (EMG) were implanted into Wistar rats. Total awake time, non-rapid eye movement (non-REM) sleep and rapid eye movement (REM) sleep were measured for 6 h. Kavain and rilmazafone showed a significant shortening in sleep latency, decreased awake time, and increased non-REM sleep time. On the other hand, significant shortening of the sleep latency was observed following the administration of diphenhydramine, while no effects were observed on the awake and non-REM sleep time. Moreover, kavain showed a significant increase in delta activity during non-REM sleep in sleep-disturbed rats, whereas a significant decrease in delta power during non-REM sleep was observed with rilmazafone. These results clearly indicate that kavain is a compound with not only hypnotic effects, but also sleep quality–enhancement effects.

We also recommend Trading Suppliers and Manufacturers of kavain (cas 1635-33-2). Pls Click Website Link as below: cas 1635-33-2 suppliers

Prev:kavain (cas 1635-33-2) analogues as potential analgesic agents
Next:Standard molar enthalpies of formation, vapour pressures, and enthalpies of sublimation of 2-chloro-4-nitroaniline and 2-chloro-5-nitroaniline)